[Use of derivatives of gamma-aminobutyric acid in psychiatric practice].
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000188:drug therapy; D000613:Aminobutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000150:complications; D004644:Emotions; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D006885:Hydroxybutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D007046:Hysteria / Q000188:drug therapy; D007275:Injections, Intravenous; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D000613:Aminobutyrates; D006885:Hydroxybutyrates; D014149:Tranquilizing Agents
Primenenie proizvodnykh gamma-aminomaslianoĭ kisloty v psikhiatricheskoĭ praktike.